Coronary Disease, Coronary Stenosis
Conditions
Keywords
Firehawk, Coronary Artery Disease, Drug Eluting Stent
Brief summary
The objective of this study is to evaluate effectiveness and safety of Firehawk® stent in the real world daily practice as compared with other drug-eluting stents.
Interventions
DEVICEFirehawk
Firehawk stent
Sponsors
CardioVascular Research Foundation, Korea
Duk-Woo Park, MD
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 19 and more * Patient with Firehawk® coronary stent
Exclusion criteria
* Intervention with Firehawk® coronary stent and other drug eluting stent at the same time * Life-expectancy less than 1 year * Cardiac shock
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR) | 1 year |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cardiac death | 5 year | — |
| Myocardial Infarction | 5 year | — |
| Composite event rate of death or myocardial infarction (MI) | 5 year | — |
| Composite event rate of cardiac death or myocardial infarction (MI) | 5 year | — |
| All cause death | 5 year | — |
| Target- Lesion Revascularization | 5 year | — |
| Stent thrombosis | 5 year | — |
| Procedural Success rate | 5 year | Procedural success rate is defined as \< 30% final stenosis and the absence of in-hospital event including death, Q wave myocardial infarction, urgent repeat revascularization. |
| Target- Vessel Revascularization | 5 year | — |
Countries
South Korea
Outcome results
None listed